Catalyst Wire Dossier Catalyst Wire Dossier

XELSTRYM

Dextroamphetamine · Noven Therapeutics, LLC
Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for XELSTRYM, covering 2022-03-22 to 2025-09-23. Get the full timeline:

Most recent: FDA Approved: XELSTRYM — Supplemental Application (Noven Therapeutics, LLC)

See pricing